Cosmetic cross-reference

Saccharin

CAS 81-07-2

Saccharin (CAS 81-07-2) is a Phase 3 pharmaceutical compound with 4 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Saccharin

CAS Number

81-07-2

UNII

FST467XS7D

InChIKey

CVHZOJJKTDOEJC-UHFFFAOYSA-N

ChEMBL ID

CHEMBL310671

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3

Late-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL310671 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 4 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	Ki	8494.13178807947 nM	151	-
-	Potency	28291.640000000003 nM	10	-
-	IC50	14517.539999999999 nM	2	-
-	AC50	44668.4 nM	1	-

SOURCE IUPHAR/BPS 2 interactions

IUPHAR Ligand-Target Data

Curated ligand-target interaction rows with action, affinity, and literature identifiers.

Target	Action	Affinity	PubMed
TAS2R31 TAS2R31	Agonist	2.9600000381469727 pEC50	15537898
TAS2R43 TAS2R43	Agonist	2.7699999809265137 pEC50	15537898

SOURCE NLM RxNorm 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
SACCHARIN	9509	SU	MTHSPL
Saccharin	9509	SU	MTHSPL
saccharin	9509	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Saccharin used for in pharmaceutical contexts?

Saccharin (CAS 81-07-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Saccharin?

No adverse-event association or SIDER side-effect rows are rendered for Saccharin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Saccharin also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Saccharin with EU status "permitted".

What clinical phase is Saccharin in?

Saccharin is rendered with ChEMBL max phase 3.